Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: A systematic review and meta-analysis
Abstract Accumulated studies have not provided conclusive evidence in regards to the comparative efficacy and safety of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas. To address this issue, we performed a meta-analysis with eight studies ide...
Gespeichert in:
| Veröffentlicht in: | Journal of the neurological sciences 2017-01, Vol.372, p.110-116 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 116 |
|---|---|
| container_issue | |
| container_start_page | 110 |
| container_title | Journal of the neurological sciences |
| container_volume | 372 |
| creator | Li, Xuezhen, MD Li, Yanbin, MD Cao, Yang, MD Li, Peiliang, MD Liang, Bo, MD Sun, Jidian, MD Feng, Enshan, MD |
| description | Abstract Accumulated studies have not provided conclusive evidence in regards to the comparative efficacy and safety of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas.
To address this issue, we performed a meta-analysis with eight studies identified from Medline, PubMed, Cochrane, Google Scholar, and published up to September 17, 2015.
Eligible studies reported the disease control rate, endocrine cure rate (for functional adenomas), the rate of occurrence of new-onset hypopituitarism, and visual disturbance rate in patients treated with either stereotactic radiosurgery or fractionated stereotactic radiotherapy.
Eight studies enrolled a total of 634 patients with pituitary adenoma, 273 patients underwent a stereotactic radiosurgery and 361 patients underwent fractionated stereotactic radiotherapy.
No significant differences were found in efficacy measures, such as disease control rate and endocrine cure rate, between stereotactic radiosurgery and fractionated stereotactic radiotherapy (OR = 1.156, p = 0.666; OR = 0.659, p = 0.153, respectively).
Additionally, meta-analysis of safety measures, such as the rate of new-onset hypopituitarism and visual disturbance rate, did not show significant differences between different treatments (OR = 1.365, p = 0.469; OR = 0.872, p = 0.845 respectively). In conclusion, both stereotactic radiosurgery and fractionated stereotactic radiotherapy have comparable efficacy and safety in the management of pituitary adenoma patients. |
| doi_str_mv | 10.1016/j.jns.2016.11.024 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1853354365</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0022510X16307274</els_id><sourcerecordid>1853354365</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-a7f547d0b24e2989fae899f2ad2d6c70e385362270fad9013bdc4855e8eadf5c3</originalsourceid><addsrcrecordid>eNp9kt-K1TAQxoMo7nH1AbyRXHrTmqRNmyoIy-I_WPBiFbwLc5KJ5tg2xyRV-kI-p-me1QsFrzJkvt8HM98Q8pizmjPePTvUhznVopQ15zUT7R2y46pXlVSquUt2jAlRSc4-nZEHKR0YY51Sw31yJhTjPR_kjvy8Bod5pTBbis55A2alwVEXwWQfZshoacoYMeTtx9AI1of8BSMcT9i_3bTEzxhX6kKkOSLkCee8uR59XnyG0gKLc5ggPacXNK3FYoIbHL97_HFjO2GGCmYY1-TTQ3LPwZjw0e17Tj6-fvXh8m119f7Nu8uLq8q0TOUKeifb3rK9aFEManCAahicACtsZ3qGjZJNJ0TPHNiB8WZvTaukRIVgnTTNOXl68j3G8G3BlPXkk8FxhBnDkjQvfCPbppNFyk9SE0NKEZ0-Rj-V2TRneotHH3SJR2_xaM51iacwT27tl_2E9g_xO48ieHESYBmyrCLqZDzOBq2PaLK2wf_X_uVftBn9XDIdv-KK6RCWWPZZptBJaKavt_vYzoN3DetF3za_ABczup4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1853354365</pqid></control><display><type>article</type><title>Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: A systematic review and meta-analysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Li, Xuezhen, MD ; Li, Yanbin, MD ; Cao, Yang, MD ; Li, Peiliang, MD ; Liang, Bo, MD ; Sun, Jidian, MD ; Feng, Enshan, MD</creator><creatorcontrib>Li, Xuezhen, MD ; Li, Yanbin, MD ; Cao, Yang, MD ; Li, Peiliang, MD ; Liang, Bo, MD ; Sun, Jidian, MD ; Feng, Enshan, MD</creatorcontrib><description>Abstract Accumulated studies have not provided conclusive evidence in regards to the comparative efficacy and safety of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas.
To address this issue, we performed a meta-analysis with eight studies identified from Medline, PubMed, Cochrane, Google Scholar, and published up to September 17, 2015.
Eligible studies reported the disease control rate, endocrine cure rate (for functional adenomas), the rate of occurrence of new-onset hypopituitarism, and visual disturbance rate in patients treated with either stereotactic radiosurgery or fractionated stereotactic radiotherapy.
Eight studies enrolled a total of 634 patients with pituitary adenoma, 273 patients underwent a stereotactic radiosurgery and 361 patients underwent fractionated stereotactic radiotherapy.
No significant differences were found in efficacy measures, such as disease control rate and endocrine cure rate, between stereotactic radiosurgery and fractionated stereotactic radiotherapy (OR = 1.156, p = 0.666; OR = 0.659, p = 0.153, respectively).
Additionally, meta-analysis of safety measures, such as the rate of new-onset hypopituitarism and visual disturbance rate, did not show significant differences between different treatments (OR = 1.365, p = 0.469; OR = 0.872, p = 0.845 respectively). In conclusion, both stereotactic radiosurgery and fractionated stereotactic radiotherapy have comparable efficacy and safety in the management of pituitary adenoma patients.</description><identifier>ISSN: 0022-510X</identifier><identifier>EISSN: 1878-5883</identifier><identifier>DOI: 10.1016/j.jns.2016.11.024</identifier><identifier>PMID: 28017195</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adenoma - radiotherapy ; Dose Fractionation ; Fractionated ; Humans ; Neurology ; Pituitary adenoma ; Pituitary Neoplasms - radiotherapy ; Radiosurgery ; Radiosurgery - adverse effects ; Radiotherapy ; Stereotactic</subject><ispartof>Journal of the neurological sciences, 2017-01, Vol.372, p.110-116</ispartof><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-a7f547d0b24e2989fae899f2ad2d6c70e385362270fad9013bdc4855e8eadf5c3</citedby><cites>FETCH-LOGICAL-c408t-a7f547d0b24e2989fae899f2ad2d6c70e385362270fad9013bdc4855e8eadf5c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022510X16307274$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28017195$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Xuezhen, MD</creatorcontrib><creatorcontrib>Li, Yanbin, MD</creatorcontrib><creatorcontrib>Cao, Yang, MD</creatorcontrib><creatorcontrib>Li, Peiliang, MD</creatorcontrib><creatorcontrib>Liang, Bo, MD</creatorcontrib><creatorcontrib>Sun, Jidian, MD</creatorcontrib><creatorcontrib>Feng, Enshan, MD</creatorcontrib><title>Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: A systematic review and meta-analysis</title><title>Journal of the neurological sciences</title><addtitle>J Neurol Sci</addtitle><description>Abstract Accumulated studies have not provided conclusive evidence in regards to the comparative efficacy and safety of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas.
To address this issue, we performed a meta-analysis with eight studies identified from Medline, PubMed, Cochrane, Google Scholar, and published up to September 17, 2015.
Eligible studies reported the disease control rate, endocrine cure rate (for functional adenomas), the rate of occurrence of new-onset hypopituitarism, and visual disturbance rate in patients treated with either stereotactic radiosurgery or fractionated stereotactic radiotherapy.
Eight studies enrolled a total of 634 patients with pituitary adenoma, 273 patients underwent a stereotactic radiosurgery and 361 patients underwent fractionated stereotactic radiotherapy.
No significant differences were found in efficacy measures, such as disease control rate and endocrine cure rate, between stereotactic radiosurgery and fractionated stereotactic radiotherapy (OR = 1.156, p = 0.666; OR = 0.659, p = 0.153, respectively).
Additionally, meta-analysis of safety measures, such as the rate of new-onset hypopituitarism and visual disturbance rate, did not show significant differences between different treatments (OR = 1.365, p = 0.469; OR = 0.872, p = 0.845 respectively). In conclusion, both stereotactic radiosurgery and fractionated stereotactic radiotherapy have comparable efficacy and safety in the management of pituitary adenoma patients.</description><subject>Adenoma - radiotherapy</subject><subject>Dose Fractionation</subject><subject>Fractionated</subject><subject>Humans</subject><subject>Neurology</subject><subject>Pituitary adenoma</subject><subject>Pituitary Neoplasms - radiotherapy</subject><subject>Radiosurgery</subject><subject>Radiosurgery - adverse effects</subject><subject>Radiotherapy</subject><subject>Stereotactic</subject><issn>0022-510X</issn><issn>1878-5883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kt-K1TAQxoMo7nH1AbyRXHrTmqRNmyoIy-I_WPBiFbwLc5KJ5tg2xyRV-kI-p-me1QsFrzJkvt8HM98Q8pizmjPePTvUhznVopQ15zUT7R2y46pXlVSquUt2jAlRSc4-nZEHKR0YY51Sw31yJhTjPR_kjvy8Bod5pTBbis55A2alwVEXwWQfZshoacoYMeTtx9AI1of8BSMcT9i_3bTEzxhX6kKkOSLkCee8uR59XnyG0gKLc5ggPacXNK3FYoIbHL97_HFjO2GGCmYY1-TTQ3LPwZjw0e17Tj6-fvXh8m119f7Nu8uLq8q0TOUKeifb3rK9aFEManCAahicACtsZ3qGjZJNJ0TPHNiB8WZvTaukRIVgnTTNOXl68j3G8G3BlPXkk8FxhBnDkjQvfCPbppNFyk9SE0NKEZ0-Rj-V2TRneotHH3SJR2_xaM51iacwT27tl_2E9g_xO48ieHESYBmyrCLqZDzOBq2PaLK2wf_X_uVftBn9XDIdv-KK6RCWWPZZptBJaKavt_vYzoN3DetF3za_ABczup4</recordid><startdate>20170115</startdate><enddate>20170115</enddate><creator>Li, Xuezhen, MD</creator><creator>Li, Yanbin, MD</creator><creator>Cao, Yang, MD</creator><creator>Li, Peiliang, MD</creator><creator>Liang, Bo, MD</creator><creator>Sun, Jidian, MD</creator><creator>Feng, Enshan, MD</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170115</creationdate><title>Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: A systematic review and meta-analysis</title><author>Li, Xuezhen, MD ; Li, Yanbin, MD ; Cao, Yang, MD ; Li, Peiliang, MD ; Liang, Bo, MD ; Sun, Jidian, MD ; Feng, Enshan, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-a7f547d0b24e2989fae899f2ad2d6c70e385362270fad9013bdc4855e8eadf5c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adenoma - radiotherapy</topic><topic>Dose Fractionation</topic><topic>Fractionated</topic><topic>Humans</topic><topic>Neurology</topic><topic>Pituitary adenoma</topic><topic>Pituitary Neoplasms - radiotherapy</topic><topic>Radiosurgery</topic><topic>Radiosurgery - adverse effects</topic><topic>Radiotherapy</topic><topic>Stereotactic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Xuezhen, MD</creatorcontrib><creatorcontrib>Li, Yanbin, MD</creatorcontrib><creatorcontrib>Cao, Yang, MD</creatorcontrib><creatorcontrib>Li, Peiliang, MD</creatorcontrib><creatorcontrib>Liang, Bo, MD</creatorcontrib><creatorcontrib>Sun, Jidian, MD</creatorcontrib><creatorcontrib>Feng, Enshan, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Xuezhen, MD</au><au>Li, Yanbin, MD</au><au>Cao, Yang, MD</au><au>Li, Peiliang, MD</au><au>Liang, Bo, MD</au><au>Sun, Jidian, MD</au><au>Feng, Enshan, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: A systematic review and meta-analysis</atitle><jtitle>Journal of the neurological sciences</jtitle><addtitle>J Neurol Sci</addtitle><date>2017-01-15</date><risdate>2017</risdate><volume>372</volume><spage>110</spage><epage>116</epage><pages>110-116</pages><issn>0022-510X</issn><eissn>1878-5883</eissn><abstract>Abstract Accumulated studies have not provided conclusive evidence in regards to the comparative efficacy and safety of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas.
To address this issue, we performed a meta-analysis with eight studies identified from Medline, PubMed, Cochrane, Google Scholar, and published up to September 17, 2015.
Eligible studies reported the disease control rate, endocrine cure rate (for functional adenomas), the rate of occurrence of new-onset hypopituitarism, and visual disturbance rate in patients treated with either stereotactic radiosurgery or fractionated stereotactic radiotherapy.
Eight studies enrolled a total of 634 patients with pituitary adenoma, 273 patients underwent a stereotactic radiosurgery and 361 patients underwent fractionated stereotactic radiotherapy.
No significant differences were found in efficacy measures, such as disease control rate and endocrine cure rate, between stereotactic radiosurgery and fractionated stereotactic radiotherapy (OR = 1.156, p = 0.666; OR = 0.659, p = 0.153, respectively).
Additionally, meta-analysis of safety measures, such as the rate of new-onset hypopituitarism and visual disturbance rate, did not show significant differences between different treatments (OR = 1.365, p = 0.469; OR = 0.872, p = 0.845 respectively). In conclusion, both stereotactic radiosurgery and fractionated stereotactic radiotherapy have comparable efficacy and safety in the management of pituitary adenoma patients.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28017195</pmid><doi>10.1016/j.jns.2016.11.024</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-510X |
| ispartof | Journal of the neurological sciences, 2017-01, Vol.372, p.110-116 |
| issn | 0022-510X 1878-5883 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1853354365 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adenoma - radiotherapy Dose Fractionation Fractionated Humans Neurology Pituitary adenoma Pituitary Neoplasms - radiotherapy Radiosurgery Radiosurgery - adverse effects Radiotherapy Stereotactic |
| title | Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: A systematic review and meta-analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T16%3A58%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20and%20efficacy%20of%20fractionated%20stereotactic%20radiotherapy%20and%20stereotactic%20radiosurgery%20for%20treatment%20of%20pituitary%20adenomas:%20A%20systematic%20review%20and%20meta-analysis&rft.jtitle=Journal%20of%20the%20neurological%20sciences&rft.au=Li,%20Xuezhen,%20MD&rft.date=2017-01-15&rft.volume=372&rft.spage=110&rft.epage=116&rft.pages=110-116&rft.issn=0022-510X&rft.eissn=1878-5883&rft_id=info:doi/10.1016/j.jns.2016.11.024&rft_dat=%3Cproquest_cross%3E1853354365%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1853354365&rft_id=info:pmid/28017195&rft_els_id=1_s2_0_S0022510X16307274&rfr_iscdi=true |